SCHEMBL30523281

SCHEMBL30523281

COC(=O)c1ccc2cnc(-c3cc(OC)c(C(C)C)c(OC)c3)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 2/20 0.42
▸ CYP19A1 P11511 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ TDO2 P48775 5/20 0.40
▸ IDO1 P14902 3/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CYP17A1 P05093 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ TTK P33981 2/20 0.38
▸ NEK2 P51955 1/20 0.37
▸ PTPN11 Q06124 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24204704 1.00 KDM5B (0.42) KDM5BCYP19A1CYP11B1CYP11B2MAPT
SCHEMBL24345996 0.93 KDM5B (0.39) KDM5BCYP19A1CYP11B1CYP11B2MAPT
SCHEMBL30390005 0.89 NEK2 (0.45) TDO2IDO1PDGFRBHTTNPC1
SCHEMBL24204669 0.89 NEK2 (0.45) TDO2IDO1PDGFRBHTTNPC1
SCHEMBL26874132 0.89 CYP2A6 (0.40) TDO2IDO1NPC1RAB9ANEK2
SCHEMBL24204822 0.80 NPC1 (0.43) MAPTTDO2IDO1PDGFRBNPC1
SCHEMBL29493153 0.80 CFTR (0.43) CYP3A4TTK
SCHEMBL24204628 0.80 CFTR (0.43) CYP3A4TTK
SCHEMBL30389877 0.79 NPC1 (0.59) MAPTTDO2IDO1PDGFRBNPC1
SCHEMBL24204600 0.79 NPC1 (0.59) MAPTTDO2IDO1PDGFRBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185566-A1 ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AHR IMBALANCE Dermavant Sciences GmbH (CH) 2023-05-31 — — EP disclosed
Send feedback